You have read all your free articles, to continue reading subscribe to read the rest of this content.
Cantargia and BioInvent International have announced that BioInvent has been contracted as manufacturer of Cantargia’s antibody CAN10 in preclinical development for the treatment of systemic sclerosis and myocarditis. CAN10 is fully humanized monoclonal antibody targeting IL1RAP. CAN10 has beenAlready a subscriber Login You have read all your free articles, to…
Orion Corporation and CuraTeQ Biologics have expanded their biosimilar distribution agreement to the Baltic countries. The original marketing and distribution agreement signed in 2020 covered the Nordics, Austria, Hungary and Slovenia. Under the agreement, Orion will have the right to sell and maAlready a subscriber Login You have read all…
The purpose is to strengthen knowledge transfer from academic research to clinical application and commercialization. The Board consists of five internationally reputable experts with extensive experience in research into diabetes and its complications. "By setting up a Scientific Advisory BoaAlready a subscriber Login You have read all your free articles,…
Allergan has entered into a global agreement with AstraZeneca to develop and commercialize ATM-AVI, an investigational, fixed-dose antibiotic combining aztreonam and avibactam. Together, the two companies will evaluate the combination to treat serious infections caused by metallo βlactamase MBL-Already a subscriber Login You have read all your free articles, to…
